Long Ideas - SciClone Pharmaceuticals (NASDAQ:SCLN) issued 2013 financial guidance earlier this week around the JP Morgan Healthcare Conference in San Francisco, with its earnings outlook anticipated to … Continue Reading
Read nowLong Ideas - Affymax (NASDAQ:AFFY) and partner Takeda announced Monday that Omontys, their erythropoietin stimulating agent (ESA), became the subject of a supply contract with dialysis supplier DSI … Continue Reading
Read nowLong Ideas - Keryx Biopharmaceuticals (NASDAQ:KERX) announced Monday morning that its Japanese development partner JT Tori Pharmaceutical Co. submitted a new drug application (NDA) for Zerenex, the company’s … Continue Reading
Read nowMost Popular - In a comment to Swiss newspaper SonntagsZeitung, Roche (OTC:RHBBY) Chairman Franz Humerstated said that a hostile bid for Illumina (NASDAQ:ILMN) is “off the table,” which … Continue Reading
Read nowMost Popular - Synageva (NASDAQ:GEVA) announced its third stock offering in twelve months on Thursday, which after a pricing update, should raise approximately $90M for pipeline development, particularly … Continue Reading
Read nowLong Ideas - Endo Health Solutions (NASDAQ:ENDP) re-established financial guidance Thursday night, re-affirming 2012’s prior outlook and, as expected, guiding expectations lower for revenue and EPS in 2013. This … Continue Reading
Read now- Biogen Idec (NASDAQ:BIIB) announced on Thursday that its late-stage amyotrophic lateral sclerosis (ALS) treatment, dexpramipexole, failed to meet its primary endpoint in a Phase III trial, causing … Continue Reading
Read now